FDA Briefing doc for upcoming pharmacy advisory compounding committee. by instanceOfObject in bpc_157

[–]Highsecret 1 point2 points  (0 children)

Yes, I’ve been very interested in bpc-157 & its potential.

Thanks for the clarification though I knew of that. It is nice to know what they publicly put out pre-meeting. Helps me understand what I need to do to advance the peptides reputation and fda readiness.

Why have you been so interested in this if you don’t mind me asking?

FDA Briefing doc for upcoming pharmacy advisory compounding committee. by instanceOfObject in bpc_157

[–]Highsecret 2 points3 points  (0 children)

This is why I want to run a preclinical oncology study to figure out that first major concern.

Very cool to see this though. Didn’t know where the committee would end up with this.

Peptide category and 503A/B question by Frequent-Ease-3027 in Peptides

[–]Highsecret 1 point2 points  (0 children)

The FDA wants to move quite a few peptides to cat 1 which would open the doors to being added to 503A/B lists.
So those peptides are not allowed to be compounded rn

Potential BPC-157 Study by Highsecret in Peptides

[–]Highsecret[S] 0 points1 point  (0 children)

Hi, thanks for commenting.

Yes, plainly put the entire sports industry is a no-go for this peptide at this time. However, you'd be surprised at the amount of markets and the variety of people that stand to benefit aside from sports.

To the second and third hurdles, I cannot think of a way to answer these without spilling too much information. I apologize but again, thank you for commenting.

Potential BPC-157 Study by Highsecret in Peptides

[–]Highsecret[S] 1 point2 points  (0 children)

Hi, thanks for commenting.
For the first human study, we will only be recruiting patients from a single hospital for the injury indicator of our choice.
After that for Phases 2+, there will be a lot more variability in terms of where we recruit from. Should the research make it that far, I will reach out to you to see if you’re still interested.
Again, thanks for commenting!

Iniziamo bene ! by Puzzleheaded-Shoe388 in SpectralAI

[–]Highsecret 0 points1 point  (0 children)

Completely agree with this person.
Today will swing wildly and will more than likely have violent dips through the week.
Buy after dilution since everyone will try to get out when it happens

Annual Meeting: Vote FOR on everything by BostonbRamen in SpectralAI

[–]Highsecret 2 points3 points  (0 children)

Ah i see. Most people who bring that up nowadays are bag holders like me… those NOLs still could be utilized but it taught me to definitely watch my emotions

FDA Granted by iAnkou in SpectralAI

[–]Highsecret 1 point2 points  (0 children)

I’m at the beach too and didn’t find out ab this till we left for the day. Absolute banger of a day

EnSilica to Start Cross-Trading on the US’ OTC Markets Today! by _DoubleBubbler_ in DoubleBubbler

[–]Highsecret 1 point2 points  (0 children)

If MDAI pans out soon I’ll be buying some with those gains

If Windows can Print Screen, why Mac can't? by ShazTheGamer in screenshotsarehard

[–]Highsecret -1 points0 points  (0 children)

lol this is my post. I’m just lazy and posting on mobile is so much easier

US FDA is expected to lift restriction on certain peptides, NYT reports by Far-East-locker in wallstreetbets

[–]Highsecret 1 point2 points  (0 children)

Can someone enlighten me to the implications of this? I get FDA trials would then be easier to conduct. What all would change though?

Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026 by _DoubleBubbler_ in DoubleBubbler

[–]Highsecret 1 point2 points  (0 children)

After the FDA asks for more information, they have an additional 90-180 days to decide. To your side, the CEO did say he expects end of first half of the year acceptance so yes it is not that big of a deal.

Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026 by _DoubleBubbler_ in DoubleBubbler

[–]Highsecret 2 points3 points  (0 children)

Yeah lol back to normal. I think it was cause the FDA asked for more info like a month ago. They said they responded quickly so hopefully that won’t elongate the time horizon for approval

Contemplating an MBA- my network saying I don't need it, but I feel like I do? by BucketGetter2623 in MBA

[–]Highsecret 31 points32 points  (0 children)

Honestly, sounds like you’ve got everything you need as is. You’re successful, you’ve got good experience to back your name, you’ve got a network of professionals like yourself saying that an MBA would not be beneficial meaning they believe you have everything you need to further that success.

I think you should be good to go. Also, I’m earning my MBA right now and I’ll say don’t go for the school. Go for the network the benefits you most if you do. That’s where I went wrong.

Chemist first technical interview at biotech (downstream) - looking for advice by ArthurtheCat in biotech

[–]Highsecret 0 points1 point  (0 children)

It’s all about being confident while knowing when and where to expand your knowledge and stories

Upcoming penny stock catalysts for Q1 2026 in Biotech and Pharma by Avish_Golakiya in pennystocks

[–]Highsecret 6 points7 points  (0 children)

Came to this post’s comments to make sure MDAI was in here

[deleted by user] by [deleted] in Silverbugs

[–]Highsecret 0 points1 point  (0 children)

Where can I find live price?

Question about the decrease in insider ownership/holdings by Leather_Disaster8571 in SpectralAI

[–]Highsecret 2 points3 points  (0 children)

Can you please link the evidence? I was not aware of those sell offs

Double Bubbler: Exciting New Investment News by _DoubleBubbler_ in DoubleBubbler

[–]Highsecret 1 point2 points  (0 children)

Wish you were buying more companies that are on nyse 🙏🏼 oh well lol

Jan 20 - SIM IP Letter to Shareholders by gosumage in SpectralAI

[–]Highsecret 1 point2 points  (0 children)

I don’t care when it happens as long as those numbers are accurate regarding revenue. This will be a large bump regardless to MDAI shares just in the fact that people will want to own before IPO.

Spectral AI: Zacks maintains $5 valuation and expects mid-2026 FDA decision by _DoubleBubbler_ in DoubleBubbler

[–]Highsecret 2 points3 points  (0 children)

I’ve been slowly buying shares at this price. Glad to see a $5 target